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ABSTRACT
Millions of children worldwide are born with rare and debilitating developmental disorders each
year. Although an increasing number of these conditions are being recognized at the molecular
level, the characterization of the underlying pathophysiology remains a grand challenge. This is
often due to the lack of appropriate patient material or relevant animal models. Dogs are coming to
the rescue as physiologically relevant large animal models. Hundreds of spontaneous genetic
conditions have been described in dogs, most with close counterparts to human rare disorders. Our
recent examples include the canine models of human Caffey (SLC37A2), van den Ende-Gupta
(SCARF2) and Raine (FAM20C) syndromes. These studies demonstrate the pathophysiological
similarity of human and canine syndromes, and suggest that joint efforts to characterize both
human and canine rare diseases could provide additional beneﬁts to the advancement of the ﬁeld
of rare diseases. Besides revealing new candidate genes, canine models allow access to
experimental resources such as cells, tissues and even live animals for research and intervention
purposes.
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Introduction
Dog, Canis lupus familiaris, is considered to be the
ﬁrst domesticated animal. Well-supported evidence
suggests that all dog breeds originate from the Eur-
asian gray wolf (Canis lupus lupus), potentially from
Southeast Asia,1 although the exact geographical
location and the timing of the process remains elu-
sive.2 The majority of the 400 current breeds, each
deﬁned by speciﬁc physical and behavioral character-
istics, are less than 200 y old. The phenotypic varia-
tion seen in dogs today is mainly a result of recent
strong artiﬁcial selection driven by dog breeders
admiring distinctive features. The establishment of
registering bodies (e.g. kennel clubs), together with
breeding standards, has led to controlled and
restricted breeding practices. Many breeds have
arisen from a limited number of founder animals
and the use of popular sires is a common practice.
As a consequence, each breed represents an isolated
breeding population with high levels of phenotypic
homogeneity, reduced genetic diversity and enrich-
ment of breed-speciﬁc disorders.
The sequencing of the canine genome and subsequent
development of powerful gene discovery tools has
remarkably facilitated gene discoveries in disease, mor-
phology and behavior.3-5 Dogs possess a unique genetic
architecture, consisting of an ancient short and recent
long-range linkage disequilibrium (LD).3,6 This genetic
architecture facilitates gene discovery by providing a
powerful mapping approach within a breed while an
across-breed mapping may signiﬁcantly narrow down
the associated region in order to expedite the identiﬁca-
tion of the causal risk variant as efﬁciently exempliﬁed in
a study of canine ectodermal dysplasia.7 The dog genome
is less divergent from the human genome than from the
mouse genome and, therefore, more of the human geno-
mic sequence can be syntenically aligned to the genome
of the dog than that of the mouse.3 Dogs have approxi-
mately the same number of genes as humans, most of
them being close orthologues.
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Dog is a large animal model and physiologically
and clinically more similar to human than mouse.
Importantly, pet dogs share also the environmental
conditions of their owners and are thus not only
affected by genetic traits but also by “life style.” Hun-
dreds of spontaneously occurring common canine
conditions are analogous to human diseases such as
diabetes, cancers, epilepsies, eye diseases and autoim-
mune diseases, not to mention the high numbers of
rare monogenic diseases. Canine heritable monogenic
diseases, with the current list of 201 known causative
genetic variants, are recorded in the public database
Online Mendelian Inheritance in Animals (OMIA)
(http://omia.angis.org.au). Most of the genes underly-
ing canine diseases are orthologues of the genes in the
corresponding human rare conditions.
Well-recorded genealogical data is also available, in
many places, for dogs, which can assist in the design
of genetic studies. Purebred dog registries are main-
tained by kennel clubs or other equivalent organiza-
tions. For example, the Finnish Kennel Club
maintains an open dog registry in Finland (http://jalos
tus.kennelliitto.ﬁ) and contains useful information
about each registered Finnish dog, e.g., pedigrees and
some results of health examinations. Dogs also have
good-quality veterinary medical care available and
professional veterinary records are essential to reliable
and successful research.
To utilize the canine models of human hereditary
disorders, we have established a comparative genetic
program in Finland with a large canine biobank,
including »60 000 samples from over 300 breeds of
dogs. Leveraging this biobank, the unique canine
genetic architecture and genomic tools, the presence
of hundreds of breed-speciﬁc conditions, and active
research participation of the canine and veterinary
communities, we have reported numerous new gene
discoveries in dogs across disease groups,7-13 includ-
ing several developmental disorders that model
human pediatric disorders. The identiﬁcation of the
genetic causes establishes the affected breeds as pre-
clinical models, including examples such as the
recombinant protein replacement for X-linked
hypohidrotic ectodermal dysplasia (XLHED),14 and
gene therapies for hemophilia A15 and retinal
degeneration.16 Given the accelerating pace of gene
discoveries, new opportunities exist for intervention
trials. A summary of the special features that facili-
tate the use of the dog as a complementary model
to human disorders is shown in Fig. 1.
Figure 1. Various clinical, genetic, physiological and environmental characteristics in dogs make them excellent comparative models for
facilitating the understanding and treatment of human disorders.
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Our most recent study revealed 3 new developmen-
tal disorders and causative genes in dogs.17 We identi-
ﬁed SLC37A2 as novel candidate gene for human
infantile cortical hyperostosis (Caffey disease) and
implicated SCARF2 and FAM20C variants in the
canine forms of van den Ende-Gupta and Raine syn-
dromes, respectively. The study demonstrates the
power of next-generation sequencing approaches in
identifying the causative genes, the molecular diagno-
ses and the names of illnesses in canine syndromes
with high relevance to rare human diseases. All 3
spontaneous canine conditions closely resemble the
human conditions and provide physiologically rele-
vant models to better understand poorly characterized
gene functions and molecular pathologies toward new
therapeutic innovations.
A novel sugar-phosphate transporter candidate
gene for infantile hyperostosis
Craniomandibular osteopathy (CMO) is a self-limit-
ing hyperostosis with a painful swelling of the jaw,
leading to dysphagia and difﬁculty in opening the
mouth in young dogs. It is equivalent to human infan-
tile cortical hyperostosis.18,19 We discovered a splicing
defect in the SLC37A2 gene in CMO and propose it as
an excellent candidate for mutation screening in Caf-
fey patients. Our discovery is important since the
molecular etiology remains unknown in many cases
and early molecular diagnosis would avoid invasive
procedures. Furthermore, it is still mechanistically
unclear how the previously-discovered missense vari-
ant in COL1A1 could lead to self-limiting hyperosto-
sis.20,21 SLC37A2 may provide new insights to disease
etiology.
SLC37A2 belongs to the SLC37 family of 4 ER-asso-
ciated glucose-phosphate transporters.22 It is abun-
dantly expressed in disease-relevant tissues such as
bone marrow and haematopoietic cell linages such as
osteoclasts and macrophages,23,24 and may play a cen-
tral role in glucose homeostasis in osteogenesis. We
hypothesize that an impaired function of SLC37A2
disturbs proper glucose supply in the osteoclasts,
decreasing their overall activity, which in turn results
in an imbalance between osteoblastic and osteoclastic
functions in the developing bones leading to hyperos-
tosis. Interestingly, SLC37A2 has been found also as a
primary target for vitamin D,25 which could be a
potent therapeutic booster to alleviate clinical signs in
affected dogs, which are due to diminished expression
of wild type expression of SLC37A2.
Our canine study not only discovered a novel
Caffey disease gene but also unraveled a physiological
function of SLC37A2, providing new insights and
hypotheses into infantile swelling diseases, which may
be related to impaired glucose homeostasis during the
bone development. The affected dogs now provide
unique resources to address these hypotheses and
other SLC37A2-related mechanisms in osteogenesis
biology.
A canine model of van den Ende-Gupta syndrome
Our second example highlights the importance of the
gene discovery to naming the illness and establishing
a model for the human syndrome. We found a severe
truncating mutation in SCARF2 in an unknown devel-
opmental syndrome in Wire Fox Terriers, character-
ized by severe mandibular prognathia and other
skeletal abnormalities. The SCARF2 mutations have
been found in less than 30 reported patients of van
den Ende-Gupta syndrome (VDEGS). These patients
are characterized by craniofacial and skeletal abnor-
malities including blepharophimosis, a ﬂat and wide
nasal bridge, narrow and beaked nose, hypoplastic
maxilla with or without cleft palate and everted lower
lip, prominent deformed ears, down-slanting eyes,
arachnodactyly and camptodactyly.26
Human and canine VDEGS patients share many
similarities, including hypoplastic maxilla, dislocated
radial head, patellar dislocation, deviated nasal septum
and small eyes.17 Therefore, the SCARF2 discovery
established the canine diagnosis and a model for
human VDEGS. This is important since the lack of a
transgenic mouse model and scarcity of human
patients highlight the role of affected dogs as a novel
resource for understanding SCARF2 functions and
molecular pathology. In addition, given that some of
the VDEGS dogs survive past 10 years, they could
potentially serve as preclinical models.
SCARF2 is a very poorly-characterized member of
the scavenger receptor type F family.27 It is a single-
pass transmembrane protein with homology to cal-
modulin (CaM)-like Ca2C-binding proteins. The
extracellular domain contains several putative epider-
mal growth factor-like (EGF) domains, and it has a
number of positively-charged residues within the
intracellular domain. Scarf2 is expressed in disease-
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relevant tissues such as epidermis, branchial arches,
mandible, maxilla and urogenital ridge tissue of devel-
oping mouse embryos.28,29 However, nothing is
known about its function.
A detailed histopathological characterization of the
canine VDEGS should be performed to learn about
SCARF2 functions, regulation and the related cellular
pathway, in order to improve our understanding of
the disease mechanisms, which in turn could lead to
therapeutic hypotheses. The established canine model
provides powerful new resources toward these aims.
A canine model of Raine syndrome
FAM20C mutations have been described in human
autosomal recessive osteosclerotic bone dysplasia
(Raine syndrome). Less than 40 cases with variable
severity and clinical heterogeneity have been reported
including those which survive into childhood.30-33
Typical characteristics include variable extent of hypo-
phosphatemia, abnormal and hypomineralized teeth,
craniofacial anomalies, such as exophthalmos, midface
hypoplasia, microcephaly and cleft palate, as well as
gingival hyperplasia, generalized osteosclerosis and
intracerebral calciﬁcations.
We found a recessive missense variant in the kinase
domain of the FAM20C gene in a family of several
affected dogs that suffered from severe dental wear
and loss of teeth. Clinical ﬁndings in dogs were limited
to severe hypomineralization of teeth, leading to
extensive wear and inﬂammation as prominent fea-
tures. We did not observe some of the typical gross
changes described in Raine patients such as hypophos-
phatemia and craniofacial anomalies. Our canine
study raises the question of whether a more limited
human phenotype exists and should be targeted for
mutation screening. However, there is a signiﬁcant
clinical heterogeneity in the symptoms between
human patients and more detailed radiographic analy-
ses should be performed in dogs to observe potential
mild changes outside the dental phenotype.
Different species may expand our understanding of
the heterogeneity of the clinical picture and provide
important information about genotype-phenotype
correlations. Fam20c-deﬁcient mice have a prominent
dental phenotype.34 Our FAM20C-deﬁcient dogs have
a dental phenotype similar to that of mice and
humans. Considering that, unlike rodents, dogs have a
dental physiology similar to that of humans, having
both deciduous and permanent dentitions, they pro-
vide a relevant preclinical model for this rare human
bone disease.
Conclusion
We and others have demonstrated that dogs carry
numerous clinically and genetically close counterparts
of human rare diseases. Better characterization and
utilization of the canine models could be highly useful,
not only for the development of new therapies for rare
human diseases, but also for the better understanding
of the molecular pathophysiology of the conditions in
general. A rapidly-growing number of new gene dis-
coveries in dogs will establish interesting new models
for human disease. Direct encouragement of private
pet owners to participate in preclinical trials could
provide a straightforward route to facilitate the valida-
tion of human treatment approaches while also
beneﬁtting canine health and welfare. The full preclin-
ical potential of canine models has not been realized
yet.
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